NIH Reporter #1R43DA064200-01

Research grant for neural exosome therapeutics to treat opioid-induced brain hypoxia injuries funded by NIDA.

This opportunity is a research grant funded by the National Institute on Drug Abuse (NIDA) for developing neural exosome therapeutics to treat opioid-induced brain hypoxia injuries. - Government Buyer: - National Institute on Drug Abuse (NIDA), a federal agency - Project location: Athens, GA - Primary Vendor Mentioned: - ARUNA BIOMEDICAL, INC. - Products/Services Requested: - Research and evaluation of neural exosome-based therapeutics for opioid-induced brain hypoxia injuries - Focus on injuries caused by fentanyl overdose - No specific part numbers or product quantities provided - Unique/Notable Requirements: - Submissions must be made electronically via the NIH Reporter portal - Opportunity classified under CFDA code 93.279 (Drug Abuse and Addiction Research) - No OEMs or commercial product manufacturers specified - Estimated Award Amount: - $399,997 - No administrative or procedural contract vehicle details included

Description

This is a research grant opportunity funded by the National Institute on Drug Abuse (NIDA) to evaluate neural exosome-based therapeutics for opioid-related brain injuries, specifically focusing on fentanyl overdose. The project aims to develop treatments for opioid-induced brain hypoxia injuries. The estimated award amount is $399,997. The application deadline is May 27, 2024, and submissions are to be made electronically via the NIH Reporter portal.

View original listing